In vitro and in vivo assays showed that exosomal SBF2-AS1 from temozolomide-resistant glioblastoma cells can accelerate DNA damage repair in recipient cells and enhance chemoresistance to temozolomide26. Here, SBF2 is linked to glioblastoma.